Heart Disease: “Good” HDL Cholesterol May Not Predict Risk

For years, HDL cholesterol enjoyed a sparkling reputation. It was the “good” cholesterol, the tidy sibling in the lipid family, the number people loved to brag about after a routine blood test. If LDL was the villain twirling its mustache, HDL was the cape-wearing hero.

But heart health, as usual, refuses to behave like a simple cartoon.

Newer research suggests that HDL cholesterol may not predict heart disease risk as reliably as many people once believed. In some groups, higher HDL does not appear to offer the protection we expected. In others, low HDL may be less informative than the rest of a person’s risk profile. That does not mean HDL is meaningless. It means HDL is no longer the only number deserving applause at your annual checkup.

If your lab report shows a shiny HDL and you are ready to throw it a parade, hold the confetti for one more minute. The bigger story may be happening elsewhere on the panel.

Why the old HDL story is being challenged

HDL stands for high-density lipoprotein. Traditionally, it has been called “good” cholesterol because it helps carry cholesterol away from the bloodstream and back to the liver, where the body can process and remove it. On paper, that sounds excellent. In biology, though, “sounds excellent” and “predicts fewer heart attacks in real life” are not always the same thing.

Older research linked higher HDL levels with lower cardiovascular risk. That association became deeply embedded in medical language, health articles, and probably a million awkward family conversations about triglycerides. But more recent studies have complicated the picture by showing that the relationship between HDL and heart disease risk is not as universal or straightforward as once assumed.

The study that pushed HDL off its pedestal

One of the most important turning points came from a large U.S. study that examined nearly 24,000 adults. Researchers found that lower HDL cholesterol predicted increased coronary heart disease risk in white adults, but not in Black adults. They also found that higher HDL cholesterol was not associated with reduced risk in either group. In plain English: having a higher HDL number did not necessarily mean extra protection.

That matters because many earlier assumptions about HDL were built from older studies that did not fully reflect the diversity of the U.S. population. When newer research included broader groups, the neat little “high HDL equals safer heart” slogan started looking more like an oversimplified bumper sticker than a reliable rule.

HDL may be a marker, not a magic shield

Another reason the story changed is that HDL appears to be more complicated than a simple quantity on a lab report. Think of it this way: owning ten pickup trucks does not guarantee your furniture will get moved. What matters is whether those trucks are running, headed in the right direction, and carrying the load.

Similarly, researchers now pay more attention to HDL function, not just HDL amount. Some HDL particles may work efficiently to remove cholesterol from artery walls. Others may be less effective, especially in the setting of inflammation, metabolic disease, smoking, or certain genetic patterns. So a high HDL level can look impressive while doing less cardiovascular heavy lifting than expected.

Why a high HDL number can be misleading

A higher HDL reading can still be part of a healthy pattern. It often travels with habits that genuinely help the heart, such as regular exercise, not smoking, and maintaining a healthy weight. The trouble starts when people assume HDL can cancel out every other risk factor like some kind of biochemical hall pass.

It cannot.

Very high HDL is not always better

Some evidence suggests that extremely high HDL levels may be associated with increased cardiovascular risk in certain people. That sounds backwards because it is backwards, at least compared with the story many of us learned. But biology loves irony.

Very high HDL may reflect genetic variants, altered HDL metabolism, heavy alcohol use in some cases, or HDL particles that do not function the way we want them to. This is one reason clinicians no longer look at an unusually high HDL and automatically declare the heart invincible.

Raising HDL with medication did not solve the problem

If higher HDL alone were the secret sauce, then drugs designed to raise HDL should have dramatically reduced heart attacks and strokes. That did not happen consistently.

Several medications and treatment strategies can increase HDL levels on a lab test. But trials have not shown that simply boosting HDL with medication reliably lowers cardiovascular events. That finding was a major clue that HDL level itself may not be the main driver. In other words, improving the scoreboard is not the same thing as winning the game.

This is a key reason modern cholesterol management focuses more heavily on lowering atherogenic particles such as LDL and non-HDL cholesterol, and in some cases checking markers like ApoB and lipoprotein(a).

What predicts heart disease risk better than HDL alone?

The more useful question is not, “Is my HDL good?” It is, “What does my entire risk picture look like?”

Heart disease risk comes from a combination of cholesterol patterns, blood vessel damage, inflammation, metabolic health, genetics, and lifestyle. A single “good” number can be comforting, but comfort and accuracy are not twins.

LDL cholesterol still matters a lot

LDL cholesterol remains a major driver of plaque buildup in the arteries. When LDL is high, cholesterol is more likely to accumulate in artery walls over time. That buildup increases the risk of heart attack and stroke. Modern guidelines continue to emphasize lowering LDL, especially for people with diabetes, established cardiovascular disease, strong family history, or multiple risk factors.

If your HDL is 72 but your LDL is 165, your lipid panel is not writing a love letter to your coronary arteries. It is sending mixed signals, and the LDL is the louder voice.

Non-HDL cholesterol may tell a fuller story

Non-HDL cholesterol includes all the cholesterol carried by particles that can contribute to plaque formation, not just LDL. That means it captures LDL, VLDL, remnant particles, and lipoprotein(a). Many experts view non-HDL cholesterol as a stronger practical measure of atherogenic risk, especially in people with high triglycerides, obesity, metabolic syndrome, or type 2 diabetes.

This is especially helpful because some people have an LDL number that looks decent while other harmful particles remain elevated. Non-HDL can help reveal that leftover risk instead of letting it hide behind a respectable haircut.

ApoB counts the risky particles

Apolipoprotein B, or ApoB, is found on the surface of atherogenic lipoproteins. Measuring ApoB can help estimate how many cholesterol-carrying particles are circulating and capable of entering artery walls. In some people, ApoB may be a more precise risk marker than LDL alone, particularly when triglycerides are high or when metabolic dysfunction is present.

This matters because two people can have the same LDL cholesterol level but very different numbers of LDL particles. More particles can mean more opportunities for arterial damage.

Lipoprotein(a) is the genetic wild card

Lipoprotein(a), often written as Lp(a), is another important marker that many people have never heard of until a cardiologist brings it up with the seriousness of someone unveiling a plot twist in season five. Lp(a) is largely determined by genetics and can raise long-term risk of heart attack and stroke even when a standard cholesterol panel looks fairly ordinary.

That is one reason many experts now recommend measuring Lp(a) at least once in adulthood. A person can have a decent HDL, acceptable total cholesterol, and still carry elevated inherited risk that deserves attention.

Risk calculators use more than cholesterol

Clinicians do not assess cardiovascular risk by staring dramatically at HDL in isolation. They look at age, sex, blood pressure, diabetes, smoking status, kidney function, body size, medication use, family history, and cholesterol values together. That broader approach is far more useful than treating HDL like a fortune cookie.

In some cases, additional testing such as a coronary artery calcium scan may be used to clarify risk, especially when the treatment decision is not obvious from the lab work alone.

What your cholesterol panel really deserves: context

A good lipid panel is not just a beauty contest for HDL. It is a risk assessment tool. And risk assessment works best when the entire picture is considered.

Scenario one: the “my HDL is high, so I’m fine” trap

Imagine someone with HDL of 68, LDL of 155, triglycerides of 190, borderline high blood pressure, and a family history of early heart disease. On the surface, the HDL looks reassuring. But the total risk picture is not reassuring at all. High HDL does not neutralize high LDL, elevated triglycerides, and inherited risk.

Scenario two: the “my HDL is low, so I’m doomed” panic

Now imagine someone with HDL of 39, but LDL of 78, normal blood pressure, no diabetes, no smoking, regular exercise, and a healthy weight. That low HDL may deserve attention, but it does not automatically place this person in the same risk category as someone with multiple major risk factors.

This is the central message: HDL can be informative, but it is not a solo performance. It is part of an ensemble cast, and some of the other actors are much louder.

How to protect your heart without obsessing over one number

If HDL is not the whole story, what should people actually do? The answer is refreshingly old-fashioned and annoyingly effective.

Focus on the habits that improve overall risk

• Follow an eating pattern rich in vegetables, fruit, beans, nuts, whole grains, and healthy fats.
• Limit trans fats, reduce saturated fat, and cut back on ultra-processed foods high in added sugar.
• Exercise regularly, aiming for consistency rather than heroic bursts of optimism every third Saturday.
• Stop smoking or vaping nicotine.
• Manage blood pressure, blood sugar, sleep, and body weight.
• Take prescribed cholesterol-lowering medication if your clinician recommends it.

These steps can improve the entire cardiovascular picture. Some may raise HDL modestly, but more importantly, they lower LDL, reduce triglycerides, improve blood vessel function, and decrease overall risk.

Do not start drinking just to raise HDL

Moderate alcohol intake has been associated with higher HDL in some studies, but that is not a prescription to pour a nightly “cardiologist’s cocktail.” Alcohol can also raise blood pressure, add calories, worsen triglycerides, and create other health risks. No responsible heart plan begins with, “Have you tried more merlot?”

Ask smarter questions at your next appointment

Instead of asking only whether your HDL is good, ask:

• What is my overall cardiovascular risk?
• How do my LDL, non-HDL, and triglycerides look together?
• Should I check ApoB or lipoprotein(a)?
• Would medication, lifestyle changes, or both make the biggest difference for me?
• Do I need more testing because of my family history or other risk factors?

Those questions turn a basic lab review into a much more useful conversation.

Experiences related to this topic: when “good” HDL creates false confidence

The experiences below are composite examples based on common real-world patterns clinicians see, not individual patient stories. They show how easy it is to misunderstand a “good” HDL result when the bigger risk picture is ignored.

One common experience is the active middle-aged runner who gets a cholesterol panel back and zeroes in on an HDL in the 70s or 80s. Because they exercise, do not smoke, and feel fit, the reaction is often immediate: “Great, my heart must be in excellent shape.” Then a closer look shows LDL in the 150s, a father who had a heart attack at 52, and blood pressure that has been creeping up for years. The emotional whiplash is real. People feel tricked by the number they were told to admire. What they learn is that fitness is valuable, but a strong HDL does not erase genetics or elevated LDL.

Another familiar experience happens after a “normal” annual exam. Someone is told their cholesterol is not too bad because HDL looks strong and total cholesterol is only mildly high. Months or years later, they develop chest symptoms, get a scan, and discover coronary calcium or plaque. Their first question is often some version of, “How could that happen? My good cholesterol was good.” The answer is usually that the heart was responding to the full burden of risk over time: LDL exposure, blood pressure, insulin resistance, inflammation, tobacco history, family risk, or lipoprotein(a). HDL had become a source of reassurance, but not necessarily a reliable shield.

Then there is the opposite story: a person sees a low HDL and becomes convinced disaster is already scheduled for Tuesday. These patients often arrive scared because their HDL is under 40, yet other parts of the picture are much better than they realize. Their LDL may be controlled, they may have quit smoking, started exercising, improved their diet, and lowered their blood sugar. In that situation, the low HDL matters less than the overall risk trend. One of the most powerful experiences for patients is realizing that heart protection is not about chasing one glamorous number. It is about steadily improving the things that truly drive disease.

Families also experience this issue together. One sibling has “beautiful” HDL and assumes all is well. Another has lower HDL and becomes the designated cholesterol worrier. Then a parent’s history or a high Lp(a) result changes the entire conversation. Suddenly, the family realizes the scoreboard they were watching was incomplete. That moment can be frustrating, but it can also be useful. People stop treating HDL like a personality test and start treating cardiovascular prevention like what it actually is: long-term risk management.

The emotional lesson is simple but important. A favorable HDL number can feel comforting, and an unfavorable one can feel scary. Neither emotion should be the final interpretation. The better move is to zoom out, review the entire lipid panel, consider blood pressure and metabolic health, and make a plan based on total risk. Hearts, unfortunately, do not grade on a curve just because one lab value has good public relations.

The bottom line

HDL cholesterol still matters, but it should not be treated as a crystal ball. Newer evidence suggests that high HDL may not reliably predict lower heart disease risk for everyone, and extremely high HDL is not automatically protective. At the same time, low HDL is only one part of the picture and may matter less than LDL, non-HDL cholesterol, triglycerides, ApoB, lipoprotein(a), blood pressure, diabetes, smoking, and family history.

The modern view is not that HDL is “bad.” It is that HDL is not enough.

So the next time someone brags about their “good” cholesterol, nod politely. Then ask about their LDL, non-HDL, triglycerides, blood pressure, family history, and overall risk. If they look annoyed, that is probably because you just upgraded the conversation from cocktail-party trivia to actual preventive cardiology.